To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. Food and Drug Administration Safety and Innovation Act. S. 3187. 112th
Cong., 2nd
sess., Placed on Calendar Senate May 16, 2012. https://www.govinfo.gov/app/details/BILLS-112s3187pcs.
APA
Congress, Senate (2012, May 16). Food and Drug Administration Safety and Innovation Act (S. 3187 (PCS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-112s3187pcs.
MLA
United States, Congress, Senate. Food and Drug Administration Safety and Innovation Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-112s3187pcs. 112th Congress, S. 3187, Placed on Calendar Senate 16 May. 2012.
Bluebook
S.3187 - 112th Congress (2011-2012): Food and Drug Administration Safety and Innovation Act, S.3187, 112th Cong. (2012), https://www.govinfo.gov/app/details/BILLS-112s3187pcs.
